Maartje van den Biggelaar/sanquin.nl
Aug 2, 2026, 08:27
Maartje van den Biggelaar: HemoTwin Opens Doors for Aspiring Researchers
Maartje van den Biggelaar, Head of Laboratory of Proteomics at Sanquin, Lecturer of Pharmaceutical Biotechnology at Utrecht University, shared a post on LinkedIn:
“Within the national phramework of HemoTwin, we are looking for 3 PhD students to advance precision hemostasis in congenital bleeding disorders and bleeding disorders of unknown cause using mass spectrometry-based proteomics.
Join our team!”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments